FT
Biotech start-up behind AstraZeneca vaccine files for US listing
Vaccitech IPO likely to be seen as a loss for London as UK seeks to become hub for life sciences investment
Vaccitech IPO likely to be seen as a loss for London as UK seeks to become hub for life sciences investment